Department of Infectious Diseases, Section for Clinical Virology, Guldhedsgatan 10 B, 413 46 Göteborg, Sweden.
J Clin Microbiol. 2010 Apr;48(4):1105-11. doi: 10.1128/JCM.01442-09. Epub 2010 Jan 27.
Chronic infection with hepatitis B virus (HBV) is an important cause of cirrhosis and cancer of the liver. HBV is currently classified into eight genotypes, A to H. Accumulated evidence shows that the genotype influences both the clinical course of infection and the response to treatment. We describe a new method for genotyping based on TaqMan real-time PCR, which identifies all HBV genotypes without post-PCR processing. In this assay, each sample is processed in four multiplex real-time PCRs, each targeting two or three genotype-specific segments of HBV. By analyzing 185 samples representing all genotypes and different proportions of genotype mixtures, we could validate high accuracy of the assay. We conclude that this new assay represents a significant advancement for both diagnostics and clinical research because it is accurate, practical, and based on a technique that is well established in many virological laboratories.
慢性乙型肝炎病毒 (HBV) 感染是肝硬化和肝癌的重要原因。HBV 目前分为 8 个基因型,即 A 到 H。大量证据表明,基因型不仅影响感染的临床过程,也影响治疗反应。我们描述了一种新的基于 TaqMan 实时 PCR 的基因分型方法,该方法无需进行 PCR 后处理即可鉴定所有 HBV 基因型。在该检测中,每个样本均在四个多重实时 PCR 中进行处理,每个 PCR 针对 HBV 的两个或三个基因型特异性片段。通过分析代表所有基因型和不同基因型混合比例的 185 个样本,我们验证了该检测方法的高度准确性。我们的结论是,由于该检测方法准确、实用,且基于许多病毒学实验室中广泛应用的技术,因此它代表了诊断和临床研究的重大进展。